Global Continuous Glucose Monitoring (CGM) Devices Market Size, Share, Forecast Report, 2019-2025

The global continuous glucose monitoring (CGM) devices market is expected to grow significantly from USD 529 million in 2018 to USD 1,263 million in 2025, at a CAGR of 12.4% from 2019 to 2025. The growth in the market is attributed to the increasing prevalence of diabetes across the globe, and growing awareness among people. In addition, increasing adoption of CGM devices is further propelling the market growth.The years used for the assessment are as follows:

Historical year: 2015, 2016, 2017

Base year: 2018

Forecast period: 2019 – 2025

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total global continuous glucose monitoring (CGM) devices market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global continuous glucose monitoring (CGM) devices market
  • Finalizing the overall size and share of the global continuous glucose monitoring (CGM) devices market

OBJECTIVES:

  • To classify the global continuous glucose monitoring (CGM) devices market into segments and analyze their growth prospects individually.
  • To analyze market trends, opportunities, drivers and restraints associated with the silicone films market.
  • Profiling key companies operating in the global silicone films market.
  • To study market response with respect to the mergers and acquisitions in the industry

CHAPTER 1. Market Scope and Methodology

1.1. Research Methodology

1.2. Research Scope & Assumptions

1.3. List of Data Sources

CHAPTER 2. Executive Summary

2.1. Global Continuous Glucose Monitoring (CGM) Devices- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market Definition

3.2. Market Segmentation

3.3. Key findings of the global continuous glucose monitoring (CGM) devices market

3.4. Market opportunities & trends

3.4.1. Growing investment by major players

3.4.2. Increasing research and development activities as well as technological advancements

3.5. Market driver analysis

3.5.1. Increasing prevalence of diabetes across the globe

3.5.2. Growing awareness among people

3.5.3. Increasing adoption of CGM devices

3.6. Market restraint analysis

3.6.1. Higher cost & accuracy issues associated with CGM devices

CHAPTER 4. Competitive Outlook

4.1. Company Share Analysis

4.2. Value Chain Analysis

4.3. Porters Five Forces Analysis

CHAPTER 5. Global Continuous Glucose Monitoring (CGM) Devices Market Size and Forecast (2015 – 2025)

5.1. Global Continuous Glucose Monitoring (CGM) Devices Market, By Component (USD Million)

5.1.1. Sensors

5.1.2. Transmitters & Receivers

5.1.3. Insulin Pumps

5.2. Global Continuous Glucose Monitoring (CGM) Devices Market, By Age Group (USD Million)

5.2.1. Children

5.2.2. Adult

5.3. Global Continuous Glucose Monitoring (CGM) Devices Market, By Distribution Channel (USD Million)

5.3.1. Online Pharmacies

5.3.2. Retail Pharmacies

5.4. Global Continuous Glucose Monitoring (CGM) Devices Market, By End-user (USD Million)

5.4.1. Clinics

5.4.2. Hospital

5.4.3. Homecare Settings

5.4.4. Others

CHAPTER 6. Global Continuous Glucose Monitoring (CGM) Devices Market, By Geography

6.1. North America Continuous Glucose Monitoring (CGM) Devices Market

6.1.1. North America Continuous Glucose Monitoring (CGM) Devices Market, By Component (USD Million)

6.1.2. North America Continuous Glucose Monitoring (CGM) Devices Market, By Age Group (USD Million)

6.1.3. North America Continuous Glucose Monitoring (CGM) Devices Market, By Distribution Channel (USD Million)

6.1.4. North America Continuous Glucose Monitoring (CGM) Devices Market, By End-user (USD Million)

6.1.5. North America Continuous Glucose Monitoring (CGM) Devices Market, By Country

 6.1.5.1. United States

 6.1.5.2. Canada

 6.1.5.3. Mexico

6.2. Europe Continuous Glucose Monitoring (CGM) Devices Market

6.2.1. Europe Continuous Glucose Monitoring (CGM) Devices Market, By Component (USD Million)

6.2.2. Europe Continuous Glucose Monitoring (CGM) Devices Market, By Age Group (USD Million)

6.2.3. Europe Continuous Glucose Monitoring (CGM) Devices Market, By Distribution Channel (USD Million)

6.2.4. Europe Continuous Glucose Monitoring (CGM) Devices Market, By End-user (USD Million)

6.2.5. Europe Continuous Glucose Monitoring (CGM) Devices Market, By Country

 6.2.5.1. France

 6.2.5.2. United Kingdom

 6.2.5.3. Switzerland

 6.2.5.4. Spain

 6.2.5.5. Slovenia

 6.2.5.6. Russia

 6.2.5.7. Sweden

 6.2.5.8. Germany

 6.2.5.9. Italy

 6.2.5.10. Rest of Europe

6.3. Asia-Pacific Continuous Glucose Monitoring (CGM) Devices Market

6.3.1. Asia-Pacific Continuous Glucose Monitoring (CGM) Devices Market, By Component (USD Million)

6.3.2. Asia-Pacific Continuous Glucose Monitoring (CGM) Devices Market, By Age Group (USD Million)

6.3.3. Asia-Pacific Continuous Glucose Monitoring (CGM) Devices Market, By Distribution Channel (USD Million)

6.3.4. Asia-Pacific Continuous Glucose Monitoring (CGM) Devices Market, By End-user (USD Million)

6.3.5. Asia-Pacific Continuous Glucose Monitoring (CGM) Devices Market, By Country

 6.3.5.1. Australia

 6.3.5.2. Singapore

 6.3.5.3. China

 6.3.5.4. India

 6.3.5.5. Japan

 6.3.5.6. Rest of Asia-Pacific

6.4. Central & South America Continuous Glucose Monitoring (CGM) Devices Market

6.4.1. Central & South America Continuous Glucose Monitoring (CGM) Devices Market, By Component (USD Million)

6.4.2. Central & South America Continuous Glucose Monitoring (CGM) Devices Market, By Age Group (USD Million)

6.4.3. Central & South America Continuous Glucose Monitoring (CGM) Devices Market, By Distribution Channel (USD Million)

6.4.4. Central & South America Continuous Glucose Monitoring (CGM) Devices Market, By End-user (USD Million)

6.4.5. Central & South America Continuous Glucose Monitoring (CGM) Devices Market, By Country

 6.4.5.1. Argentina

 6.4.5.2. Brazil

 6.4.5.3. Rest of Central & South America

6.5. Middle East and Africa Continuous Glucose Monitoring (CGM) Devices Market

6.5.1. Middle East and Africa Continuous Glucose Monitoring (CGM) Devices Market, By Component (USD Million)

6.5.2. Middle East and Africa Continuous Glucose Monitoring (CGM) Devices Market, By Age Group (USD Million)

6.5.3. Middle East and Africa Continuous Glucose Monitoring (CGM) Devices Market, By Distribution Channel (USD Million)

6.5.4. Middle East and Africa Continuous Glucose Monitoring (CGM) Devices Market, By End-user (USD Million)

6.5.5. Middle East and Africa Continuous Glucose Monitoring (CGM) Devices Market, By Country

  6.5.5.1. Saudi Arabia

  6.5.5.2. South Africa

  6.5.5.3. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. Abbott Laboratories

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. Animas Corporation

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. Pfizer Inc.

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. DexCom, Inc.

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. Baxter International, Inc.

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. Echo Therapeutics, Inc.

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Medtronic PLC

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. F. Hoffmann-La Roche Ltd.

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Novo Nordisk A/S

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. Insulet Corporation

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert